Aptus Therapeutics Private Limited
About Aptus Therapeutics Private Limited
Data last updated:
Aptus Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC071724. Its GSTIN is 36AAJCA1480E1ZW (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹3 Lakh. It is led by directors Sirisha Tiyyagura and Koti Reddy Tiyyagura.
Its last annual general meeting (AGM) was held on 03 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.105 Road No.8 Aleap Industrial Area Pragathinagar Kukatpally, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.81 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹45,387 (net margin -1.4%) and EBITDA of -₹19,886 (EBITDA margin -0.6%). Revenue has declined at a compounded annual rate (CAGR) of 53% over three years and 21% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in April 2020.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Aptus Therapeutics has one previous CIN (Corporate Identification Number): U24232AP2010PTC071724. The current CIN is U24232TG2010PTC071724, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC071724 | Current |
| U24232AP2010PTC071724 | Previous |
Contact details
Aptus Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.105 Road No.8 Aleap Industrial Area Pragathinagar Kukatpally, Hyderabad, Telangana, India – 500090
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Aptus Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aptus Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aptus Therapeutics Private Limited, buy the company report.
Financials of Aptus Therapeutics Private Limited
FY 2024 filings availableAptus Therapeutics Private Limited reported revenue of ₹31.81 Lakh (down 78% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 78% fall in the latest year. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19,886 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹45,387 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.6% | ||||
| Net Profit Margin | -1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aptus Therapeutics Private Limited, buy the company report.
Board of directors of Aptus Therapeutics Private Limited
Aptus Therapeutics has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirisha Tiyyagura Also directs: Krealife Bio Medical Research Private Limited | Director | 29 Jul 2023 | 3 Years 3 Months | Current |
| Koti Reddy Tiyyagura | Director | 16 Dec 2010 | 15 Years 10 Months | Current |
Auditor
Aptus Therapeutics Private Limited is audited by V JAGADEESH & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V JAGADEESH & CO | FY 2021 | 018442S |
Shareholding
The shareholding of Aptus Therapeutics Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Aptus Therapeutics Private Limited, buy the company report.
Deals & funding
Aptus Therapeutics Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in April 2020.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2020 | Secondary share transfer | Undisclosed | Buyer: Fleming Laboratories Limited Seller: 2 individuals |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2012 | Funding round | ₹2 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Aptus Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aptus Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aptus Therapeutics Private Limited has a workforce of 9 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Aptus Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA1480E1ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aptus Therapeutics Private Limited, buy the company report.
Recent activity
Aptus Therapeutics Private Limited has 8 board changes on record since 2010: 2 appointments and 6 cessations. The latest: Harinadh Reddy Pamulapati ceased to be Additional Director on 29 Jul 2023.
Frequently asked questions
Aptus Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 December 2010 (16+ years old) and is registered under CIN U24232TG2010PTC071724.
Aptus Therapeutics has 2 current directors:
- Sirisha Tiyyagura - Director
- Koti Reddy Tiyyagura - Director
The latest financial statements of Aptus Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 03 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aptus Therapeutics is 36AAJCA1480E1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Aptus Therapeutics is U24232TG2010PTC071724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aptus Therapeutics was incorporated on 16 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aptus Therapeutics has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in April 2020.
Harinadh Reddy Pamulapati ceased to be Additional Director on 29 Jul 2023. Sirisha Tiyyagura was appointed as Director on 29 Jul 2023. Sirisha Tiyyagura ceased to be Director on 07 Jul 2022. Aptus Therapeutics has 8 board changes on record in total.
The registered office of Aptus Therapeutics is at Plot No.105 Road No.8 Aleap Industrial Area Pragathinagar Kukatpally, Hyderabad, Telangana, India – 500090.
Aptus Therapeutics operates in the pharma industry, in the pharma contract r and d segment.